Curative Biotechnology Inc
CUBT
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.14M
Close$
$-0.00
100.1% downside
Current Fair Value
100.1% downsideOvervalued by 100.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.14 Million |
|---|---|
| Enterprise Value | $7.35 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.35 |
| Outstanding Shares | 8,257,379 |
Return
| Return on Equity | 37.00% |
|---|---|
| Return on Assets | -109.54% |
| Return on Invested Capital | 25.36% |
Valuation & Multiples
| P/E Ratio | -2.22 |
|---|---|
| PEG | -8.43 |
| Price to Sales | - |
| Price to Book Ratio | -0.9 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.54 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | -0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data